. VCAM-1 modulates ABCG2 and CD44 promoter activity. Luciferase activity driven by the CD44 (−1262/+109) and ABCG2 promoters was compared between NMuMG VCAM-1 and NMuMG control cells. Firefly and Renilla luciferase activities were measured by the dual-luciferase reporter assay. To normalize the transfection efficiency, a fixed amount of pRL-CMV reporter, constitutively expressing the R. reniformis luciferase gene, was included in each sample. Graphs represent the mean of at least three independent experiments. Standard deviations are indicated. * p < 0.05. Figure S3 . Knockdown of VCAM-1 reduces CD44 and ABCG2 protein levels in MDAMB231 cells. Protein levels of VCAM-1, CD44, and ABCG2 in MDAMB231 and MDAMB231 shVCAM-1 cells were determined by Western blotting. Anti-β-actin was used as a loading control. Figure S4 . Schematic diagram of putative transcriptional factors binding sites in the VCAM-1 promoter. A plausible promoter region of 2.5 kb upstream to the VCAM-1 translation start site was obtained from UCSC genome database (http://genome.ucsc.edu/), and prediction of putative transcription factor binding sites was performed using MatInspector version 2.2 (http://www.genomatix.de/products/MatInspector/).
